$TXMD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TherapeuticsMD, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TherapeuticsMD, Inc.. Get notifications about new insider transactions in TherapeuticsMD, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 368,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 368,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 460,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 460,910 | |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.81 | 92,000 | 442,060 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.81 | 92,000 | 442,060 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.86 | 92,000 | 447,028 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.86 | 92,000 | 447,028 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 28 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 366,110 | |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 457,510 | |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.74 | 91,400 | 432,870 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.75 | 91,400 | 433,876 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Nov 21 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 774,255 | |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 903,255 | |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.99 | 129,000 | 643,581 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.82 | 129,000 | 621,651 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 16 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 548,100 | |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 640,310 | |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.83 | 91,400 | 441,096 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.93 | 91,400 | 450,236 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Option Exercise | M | 0.38 | 40,000 | 15,200 | 220,000 | |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Sell | S | 4.85 | 40,000 | 194,000 | 0 | 40 K to 0 (-100.00 %) |
| Nov 13 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Buy | M | 0.38 | 40,000 | 15,200 | 40,000 | 0 to 40 K |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 736,910 | |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 828,910 | |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.12 | 92,000 | 470,764 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,308 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 29 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,032,255 | |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,157,255 | |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.37 | 125,000 | 671,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.33 | 125,000 | 666,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 25 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 731,710 | |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 823,110 | |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.51 | 91,400 | 503,614 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.61 | 91,400 | 512,754 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 22 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 920,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 920,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,012,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,012,910 | |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,216 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.45 | 92,000 | 501,216 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.65 | 92,000 | 519,616 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.65 | 92,000 | 519,616 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 15 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,282,255 | |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,407,255 | |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.76 | 125,000 | 719,625 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.95 | 125,000 | 743,125 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Oct 11 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 914,510 | |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 1,005,910 | |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.93 | 91,400 | 542,002 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.89 | 91,400 | 538,346 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 09 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 1,097,310 | |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 1,188,710 | |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.55 | 91,400 | 598,579 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.63 | 91,400 | 605,982 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Oct 01 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,532,255 | |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,657,255 | |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.78 | 125,000 | 847,000 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.78 | 125,000 | 847,250 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 27 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,104,910 | |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,196,910 | |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.67 | 92,000 | 613,640 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.58 | 92,000 | 605,360 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 24 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 1,280,110 | |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 1,371,510 | |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.35 | 91,400 | 579,933 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.26 | 91,400 | 571,707 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Sep 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,782,255 | |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 125,000 | 12,725 | 1,907,255 | |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 434,814 | 0 to 434.8 K |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 0 | 434.8 K to 0 (-100.00 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.13 | 125,000 | 765,750 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.07 | 125,000 | 758,125 | 1,472,419 | 1.6 M to 1.5 M (-7.83 %) |
| Sep 12 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 125,000 | 12,725 | 1,597,419 | 1.5 M to 1.6 M (+8.49 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,288,910 | |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 1,380,910 | |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.22 | 92,000 | 572,240 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.25 | 92,000 | 575,000 | 18,393,559 | 18.5 M to 18.4 M (-0.50 %) |
| Sep 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,485,559 | 18.4 M to 18.5 M (+0.50 %) |
| Aug 23 2018 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.53 | 4,000 | 22,100 | 683,500 | 679.5 K to 683.5 K (+0.59 %) |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 6.35 | 75,000 | 476,250 | 75,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Jul 05 2018 | TXMD | TherapeuticsMD, In ... | Barlow Jane F | Director | Option Exercise | A | 6.35 | 50,000 | 317,500 | 50,000 | |
| Apr 18 2018 | TXMD | TherapeuticsMD, In ... | Barlow Jane F | Director | Option Exercise | A | 5.72 | 50,000 | 286,000 | 50,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 5.16 | 440,000 | 2,270,400 | 440,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 5.16 | 170,000 | 877,200 | 170,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 5.16 | 440,000 | 2,270,400 | 440,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 5.16 | 170,000 | 877,200 | 170,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 5.16 | 100,000 | 516,000 | 100,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 5.16 | 100,000 | 516,000 | 100,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 5.16 | 170,000 | 877,200 | 170,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 5.16 | 170,000 | 877,200 | 170,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 5.16 | 170,000 | 877,200 | 170,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 5.16 | 270,000 | 1,393,200 | 270,000 | |
| Dec 11 2017 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.21 | 5,000 | 31,050 | 679,500 | 674.5 K to 679.5 K (+0.74 %) |
| Sep 01 2017 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.99 | 5,000 | 29,950 | 674,500 | 669.5 K to 674.5 K (+0.75 %) |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 5.80 | 50,000 | 290,000 | 50,000 | |
| Jun 23 2017 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 5.80 | 75,000 | 435,000 | 75,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 6.83 | 260,000 | 1,775,800 | 260,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 6.83 | 170,000 | 1,161,100 | 170,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 6.83 | 170,000 | 1,161,100 | 170,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 6.83 | 170,000 | 1,161,100 | 170,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 6.83 | 445,000 | 3,039,350 | 445,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 6.83 | 40,000 | 273,200 | 40,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 |